We are live on ! Find out more
FENC icon

Fennec Pharmaceuticals
FENC

18 hedge funds and large institutions have $72.3M invested in Fennec Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more funds holding

Funds holding: 13 → 18 (+5)

25% more capital invested

Capital invested by funds: $57.7M → $72.3M (+$14.6M)

11.88% more ownership

Funds ownership: 33.07% → 44.94% (+12%)

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OM
Opaleye Management
Massachusetts
+$8.45M
2
EAM
Eventide Asset Management
Massachusetts
+$7.4M
3
ACA
Avoro Capital Advisors
New York
+$1.39M
4
PI
Putnam Investments
Massachusetts
+$1.17M
5
6CM
683 Capital Management
New York
+$587K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
1
Southpoint Capital Advisors
New York
$40.1M – – –
6CM
2
683 Capital Management
New York
$8.69M +$587K +58,820 +7%
OM
3
Opaleye Management
Massachusetts
$8.49M +$8.45M +846,900 New
EAM
4
Eventide Asset Management
Massachusetts
$7.39M +$7.4M +741,175 New
ACA
5
Avoro Capital Advisors
New York
$2.73M +$1.39M +139,334 +209%
ACP
6
Acuta Capital Partners
California
$2.5M – – –
PI
7
Putnam Investments
Massachusetts
$1.17M +$1.17M +117,645 New
GIM
8
Granahan Investment Management
Massachusetts
$592K +$94.3K +9,451 +19%
USAA
9
United Services Automobile Association
Texas
$527K +$117K +11,708 +28%
CCMINC
10
Cardinal Capital Management Inc (North Carolina)
North Carolina
$120K +$120K +12,037 New
HFM
11
Hartford Financial Management
Connecticut
$21K +$9.98K +1,000 +87%
TRCT
12
Tower Research Capital (TRC)
New York
$14K +$6.89K +691 +173%
UBS Group
13
UBS Group
Switzerland
$8K +$7.33K +734 +929%
Deutsche Bank
14
Deutsche Bank
Germany
$6K +$5.98K +599 +11,980%
Morgan Stanley
15
Morgan Stanley
New York
$4K +$3.65K +366 New
Toronto Dominion Bank
16
Toronto Dominion Bank
Ontario, Canada
$1K +$509 +51 +850%
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
$32 – – –

FENC Hedge Fund Activity: Q4 2017 in Review

18 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q4 2017, worth a combined $72.3M — up 25% from $57.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FENC positions and 0 closed out — a net gain of 5 holders — while 9 added to existing stakes and 0 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $8.45M.

  • 18 institutional investors held Fennec Pharmaceuticals (FENC) as of Q4 2017, up from 13 in Q3 2017.
  • Funds reported $72.3M of Fennec Pharmaceuticals stock for Q4 2017, up 25% quarter-over-quarter.
  • 5 funds opened new Fennec Pharmaceuticals positions in Q4 2017 and 0 closed out, a net change of +5 holders.
  • The largest Fennec Pharmaceuticals buyer in Q4 2017 was Opaleye Management, an estimated $8.45M added.

Based on aggregated 13F filings for Q4 2017.